CIFR is down 13.5% on the week and bears are still not covering, a stubborn short position now sitting at a month-long high with the analyst community more divided than at any point this year.
Short interest has climbed to 19.2% of the free float, up 10.4% week-on-week and 25.4% above where it was a month ago. The direction has been relentless: shorts added through the prior week's rally and kept adding through this week's retreat. The ORTEX short score has risen to 66.1, up from 62.9 ten days ago, placing CIFR in the seventh percentile for short intensity within its sector. The borrow market remains accessible, with availability at 120.5%, down from roughly 150% a week ago, a 19.5% tightening that reflects growing demand for borrows. There is still more than one share available for every one already on loan, so the lending pool is not yet constrained. Cost to borrow holds at 0.53%, meaning the carry cost of maintaining a short position gives bears no reason to exit.
Options positioning tells a more bullish story, which sharpens the conflict. The put/call ratio on September 29 came in at 0.30, close to its 52-week low of 0.27 and well below its 20-day average of 0.31. Call demand is dominating the options market even as the stock falls, a divergence from what the short book is saying. Retail attention has also spiked: the ORTEX Wikipedia views signal carries a z-score of 2.67, among the highest readings for this name in recent months. That elevated attention, combined with call-skewed options, suggests a segment of the market is still leaning bullish into weakness.
The Street is the most interesting part of this week's setup. Four firms initiated coverage in the past two weeks, and they landed in very different places. UBS launched at Buy with a $23 target. Rothschild came in at Neutral with an $18 target. Wells Fargo started at Overweight with $25. Freedom Capital initiated at Hold with $22. Morgan Stanley, already on the stock, raised its target from $43.50 to $54 on September 18, the most aggressive call on the register. The consensus stays at Buy across 15 analysts, with a mean target of $30.93, implying roughly 87% upside from the current $16.51. The bull case centres on the 700 MW contracted backlog anchored by AWS and Fluidstack, the $4.5 billion in secured debt at attractive terms, and two consecutive early project deliveries. Bears point to a $267.5 million GAAP net loss in Q2 2026, $66.7 million in quarterly interest expense, concentrated ERCOT exposure, and a large pipeline where none of the incremental sites carries a disclosed HPC lease today. The EPS surprise factor score ranks in the 96th percentile, though 30-day EPS momentum has collapsed to the bottom of the universe at the first percentile.
One ownership development is worth noting. V3 Holding Ltd, a Schedule 13D activist that first filed in July 2025 and has now filed 13 amendments, transferred 1.8 million shares on September 28 via a non-market transaction. Its disclosed stake has edged down from 15.0% to 14.6%. V3 remains the largest single holder at around 14% of shares, but the direction of that stake, however gradually, is lower. As with all 13D/G filings, the disclosed percentage reflects the position as last reported; holders dropping below 5% are not required to file again.
Earnings are due October 27, 27 days away. The last print, in August, produced a one-day move of minus 22.6% and a five-day move of minus 28.8%. The peer group has moved in lockstep with CIFR this week: WULF fell 12.9%, CORZ dropped 13.2%, HUT down 12.9%, and IREN lost 14.8%. This is a sector-wide retreat, not a CIFR-specific event, which makes the stubborn growth in the short position the key variable to watch into the October print.
See the live data behind this article on ORTEX.
Open CIFR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
